Literature DB >> 16247457

Molecular determinants of Akt-induced keratinocyte transformation.

C Segrelles1, M Moral, M Fernanda Lara, S Ruiz, M Santos, H Leis, R García-Escudero, A B Martínez-Cruz, J Martínez-Palacio, P Hernández, C Ballestín, J M Paramio.   

Abstract

The PI3K/PTEN/Akt signaling pathway has emerged in recent years as a main player in human cancers, increasing proliferation and decreasing apoptosis of transformed cells, and thus becoming a potential target for therapeutic intervention. Our previous data have demonstrated that Akt-mediated signaling is of a key relevance in the mouse skin carcinogenesis system, one of the best-known models of experimental carcinogenesis. Here, we investigated the involvement of several pathways as mediators of Akt-induced increased proliferation and tumorigenesis in keratinocytes. Tumors produced by subcutaneous injection of Akt-transformed keratinocytes showed increased Foxo3a phosphorylation, but no major alterations in p21(Cip1/WAF1), p27(Kip1) or mdm2 expression and/or localization. In contrast, we found increased expression and nuclear localization of DeltaNp63, beta-catenin and Lef1. Concomitantly, we also found increased expression of c-myc and CycD1, targets of the beta-catenin/Tcf pathway. Such increase is associated with increased phosphorylation and stabilization of c-myc protein as well as increased translation of c-myc and CycD1 due to mTOR activation. Using immunohistochemistry approaches in samples of oral dysplasias and human head and neck squamous cell carcinomas, we confirmed that increased Akt activation significantly correlates with increased DeltaNp63 and CycD expression, c-myc phosphorylation and nuclear accumulation of beta-catenin. Collectively, these results demonstrate that Akt is able to transform keratinocytes by specific mechanisms involving transcriptional and post-transcriptional processes. Oncogene (2006) 25, 1174-1185. doi:10.1038/sj.onc.1209155; published online 17 October 2005.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16247457     DOI: 10.1038/sj.onc.1209155

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

1.  ΔNp63α regulates keratinocyte proliferation by controlling PTEN expression and localization.

Authors:  M K Leonard; R Kommagani; V Payal; L D Mayo; H N Shamma; M P Kadakia
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway.

Authors:  Ping Lin; Xicai Sun; Tian Feng; Haifeng Zou; Ying Jiang; Zijun Liu; Dandan Zhao; Xiaoguang Yu
Journal:  Mol Cell Biochem       Date:  2011-08-12       Impact factor: 3.396

Review 3.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

4.  Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  L Allyson Checkley; Okkyung Rho; Tricia Moore; Steve Hursting; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

Review 5.  Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.

Authors:  C S Scanlon; E A Van Tubergen; R C Inglehart; N J D'Silva
Journal:  J Dent Res       Date:  2012-11-05       Impact factor: 6.116

6.  Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma.

Authors:  Janine G Einspahr; Valerie Calvert; David S Alberts; Clara Curiel-Lewandrowski; James Warneke; Robert Krouse; Steven P Stratton; Lance Liotta; Caterina Longo; Giovanni Pellacani; Giovanni Pellicani; Anil Prasad; Paul Sagerman; Yira Bermudez; Jianghong Deng; G Timothy Bowden; Emanuel F Petricoin
Journal:  Cancer Prev Res (Phila)       Date:  2012-03

7.  The thyroid hormone receptors as modulators of skin proliferation and inflammation.

Authors:  Constanza Contreras-Jurado; Laura García-Serrano; Mariana Gómez-Ferrería; Clotilde Costa; Jesús M Paramio; Ana Aranda
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

8.  Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; M Fernanda Lara; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Kaoru Kiguchi; Agueda Buitrago; Clotilde Costa; Cristina Saiz; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; Marina Garín; Teresa Grande; Ana Bravo; John DiGiovanni; Jesús M Paramio
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

9.  Transgenic mice expressing constitutively active Akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Agueda Buitrago; Clotilde Costa; Cristina Saiz; José M Ariza; Marta Dueñas; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; John Digiovanni; Jesús M Paramio
Journal:  In Vivo       Date:  2009 Sep-Oct       Impact factor: 2.155

10.  Constitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signaling.

Authors:  Carmen Segrelles; Marta Moral; Corina Lorz; Mirentxu Santos; Jerry Lu; José Luis Cascallana; M Fernanda Lara; Steve Carbajal; Ana Belén Martínez-Cruz; Ramón García-Escudero; Linda Beltran; José C Segovia; Ana Bravo; John DiGiovanni; Jesús M Paramio
Journal:  Mol Biol Cell       Date:  2007-10-24       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.